Invention Grant
US09259458B2 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
有权
至少一种肉毒杆菌神经毒素治疗与糖尿病性神经病变相关的疼痛的治疗用途
- Patent Title: Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
- Patent Title (中): 至少一种肉毒杆菌神经毒素治疗与糖尿病性神经病变相关的疼痛的治疗用途
-
Application No.: US14174911Application Date: 2014-02-07
-
Publication No.: US09259458B2Publication Date: 2016-02-16
- Inventor: Christine Favre , Michel Auguet , Piere-Etienne Chabrier De Lassauniere
- Applicant: IPSEN PHARMA S.A.S.
- Applicant Address: FR Boulogne-Billancourt
- Assignee: IPSEN PHARMA S.A.S.
- Current Assignee: IPSEN PHARMA S.A.S.
- Current Assignee Address: FR Boulogne-Billancourt
- Agency: Hunton & Williams LLP
- Priority: FR0802321 20080425
- Main IPC: A61K38/48
- IPC: A61K38/48 ; A61K38/16
Abstract:
The present invention relates to at least one botulinum neurotoxin for treatment or prevention of pain associated with diabetic neuropathy wherein said botulinum neurotoxin is prepared for local administration, wherein the local administration is not in the central nervous system (CNS), and wherein pain is treated at a site distant to the site of administration.
Public/Granted literature
- US20140154781A1 Therapeutic Use of Botulinum Neurotoxin in the Treatment of pain associated with diabetic neuropathy Public/Granted day:2014-06-05
Information query
IPC分类:
